Search for: "Teva USA"
Results 681 - 700
of 716
Sorted by Relevance
|
Sort by Date
Celanese v. ITC: Can a Secret Manufacturing Process Be Patented After Sale of the Resulting Product?
4 Mar 2024, 9:45 am
Teva Pharmaceuticals USA, Inc. held that in the AIA, Congress did not change the meaning of “on sale” from the pre-AIA statute. [read post]
30 Apr 2011, 5:22 am
Teva Pharms. [read post]
21 Jun 2018, 4:00 pm
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
5 May 2010, 10:14 pm
Teva Pharms. [read post]
18 Jul 2013, 10:45 am
Teva Pharmaceuticals, 726 F. [read post]
11 Mar 2015, 9:10 pm
Teva Pharms. [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
5 Jul 2008, 11:05 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
20 Jun 2018, 5:00 pm
Teva Pharmaceuticals USA Inc., 17-1229, the bar section will be completely full on the day it is argued. [read post]
2 Sep 2024, 5:52 pm
In Teva Pharms., USA, Inc. v. [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting and brand… [read post]
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
10 Feb 2023, 4:44 am
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
5 Apr 2012, 11:54 am
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]
21 Apr 2011, 1:36 pm
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
15 Oct 2018, 7:05 am
Justice Kavanaugh being seated prior to the second week of oral arguments in October means that most of the cases on the docket in the October Term will be heard by a complete Court of 9 Justices; thus avoiding the dreaded 4-4 split. [read post]
28 Apr 2010, 10:51 am
Teva Pharm. [read post]
29 Apr 2011, 1:03 pm
Teva Pharms. [read post]
30 Mar 2022, 7:56 am
by Dennis Crouch Functional claim language has long been a mainstay of U.S. patent law. [read post]